# Biomat USA, Inc – FDA Inspection, Feb 11, 2020

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/1ee54935-b374-4dbd-9c75-ca97263daa21
Source feed: FDA_Inspections

> FDA inspection 1118061 of Biomat USA, Inc, February 11, 2020. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 606 and 640. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1118061
- Company Name: Biomat USA, Inc
- Inspection Date: 2020-02-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1220609 - 2023-10-13
- FDA Inspection 1018966 - 2017-07-20
- FDA Inspection 938657 - 2015-08-18
- FDA Inspection 849952 - 2013-09-25
- FDA Inspection 721933 - 2011-05-05

Company: https://www.keypedia.com/companies/biomat-usa-inc/5468316d-22c2-45ea-919a-4b2a58e3eaf7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d